<DOC>
	<DOCNO>NCT01487278</DOCNO>
	<brief_summary>This large , community-based , cluster-randomized trial compare routine prophylactic use 600 mcg oral misoprostol 10 IU oxytocin deliver UnijectTM intramuscularly third stage labor .</brief_summary>
	<brief_title>Comparing Misoprostol Oxytocin UnijectTM Postpartum Hemorrhage ( PPH ) Prevention Mali</brief_title>
	<detailed_description>This study assess programmatic implication ( include feasibility , acceptability , cost , risk benefit ) community level introduction misoprostol and/or oxytocin UnijectTM prevention PPH help identify appropriate niche drug .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>woman deliver home train study provider able provide inform consent woman know contraindication prostaglandin</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>prevention</keyword>
	<keyword>misoprostol</keyword>
	<keyword>Uniject</keyword>
	<keyword>oxytocin</keyword>
</DOC>